Lidocaine is the preferred antiarrhythmic for emergency control of cardiac arrhythmias following acute myocardial infarction because (a) It has a rapidly developing and titratable antiarrhythmic action (b) It casues little myocardial depression and hypotension (c) It has broad spectrum antiarrhythmic efficacy in atrial as well as ventricular arrhythmias (d) Both (a) and (b)